Applied Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Hello, welcome to this presentation with Applied Therapeutics. I'm pleased to be joined by Shoshana Shendelman. She's the Founder and CEO of the company, who will be presenting an update, and then we'll have a few minutes for Q&A. Thanks so much for being with us, Shoshana.
Thanks, Joe. So I'll just give a quick overview to start on what we're doing in Applied Therapeutics, our business strategy, our pipeline, and then we can delve into some of the details. We did have a data readout just this morning, so it's great timing.
So we are developing drugs specifically for diseases that have no treatment options available, but where there's a very clear and well understood biology of disease, and where we have technological advancement that can allow us to move quickly through development. As you'll see, especially in the data today, we use biomarkers early on to make sure that the drugs are working the way that we think they are, ensure that we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |